CClinicalTrials.gg
Status unknownNCT01494246TABATICUpdated Jun 19, 2014

Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption

A Phase 4 interventional study of electronic mail in Tobacco Dependence and Cessation of Smoking, sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-06-19.

Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Phase 4 and Interventional

The sponsor has not verified this record recently (last verified Jun 2014), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
1,064
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Objectives. To evaluate the effectiveness and cost effectiveness of clinical practice guide based intervention with two face-to-face visits and e-mail tracking compared to brief advice to obtain continued smoking abstinence at 6 and 12 months after intervention.

Methodology. simple randomized controlled multicentric trial. All smokers (N=1064) aged 18 or older that attend by any reason to the primary care center and that have an e-mail account and they checked it at least once a week will be invited to participate. The enrolled participants will be randomly divided into control (N=532) and intervention group (N=532). An intensive intervention, based on the recommendations of the clinical practice guides, that will include six contacts (2 face-to-face and 4 by e-mail) will be applied to the intervention group. Control group will receive brief advice.

The main dependent variable will be continued abstinence of tobacco consumption at six and twelve months after the beginning of the intervention which will be validated by and a carbon monoxide breathe analysis measured by a cooximeter in standard conditions. Secondary variables will include: stage change on the quitting smoking process and evaluation of the effectiveness on the reduction of the number of smoked cigarettes at six and twelve months after intervention. A descriptive analysis of all variables will be done. A multivariate analysis will be undertaken to assess differences among intervention and control group; logistic regression for dichotomic variables and lineal regression for continuous variables.

Read the detailed description

In preliminary phase is planned to carry out 2 descriptive sub-studies: a qualitative one, which will reflect the views of patients and physicians regarding the use of email as a smoking cessation intervention, and another smoker's profile in relation to Information and Communication Technologies (ICT), which collects information on the actual use of them in smokers. The result of both will help to release data on the type of participants who would be involved in the clinical trial.

02

Conditions studied

  • Tobacco Dependence
  • Cessation of Smoking

Browse trials for

Keywords

  • Adult
  • computer-assisted instruction
  • electronic mail
  • program evaluation
  • smoking cessation/methods
  • continued abstinence
03

In context

Tobacco Use Disorder

968 studies on the registry are indexed under Tobacco Use Disorder; 126 are open to participants now.

This study's planned enrollment of 1,064 is above the median of 89 across 851 interventional studies indexed under Tobacco Use Disorder.

Browse Tobacco Use Disorder studies →

Lead sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina is the lead sponsor of 158 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Smokers over 18 years old with an e-mail account who use frequently. (Smoker is an individual who smokes any amount of tobacco, whatever this amount it is.
  • E-mail regular user is the one who uses it as a way of communication at least once per week)

Exclusion criteria

Exclusion Criteria:

  • Not regular e-mail users,
  • patients who have diseases that advise not to stop smoking:
  • Terminal diseases
  • Serious psychiatric disorders
  • Active addiction to other psychoactive drugs
  • Patients in smoking cessation process
  • whatever the cause that does not allow to understand goals and methodology of the study
05

Study design

Phase
Phase 4
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,064 participants (estimated)

Study arms

  • Experimental
    electronic mail

    Other: electronic mail

  • No intervention
    brief advise

Interventions

  • Otherelectronic mail

    Some e-mail will be sent to participants who will be in the intervention group in order to intensify the brief advise received for stop smoking.

    Also known as: e-mail, electronic mail, computer intervention,

06

What researchers measure

Primary outcomes

  1. Change in smoking status and maintenance in smoking cessation

    The term used to name long term abstinence over 6 months is continuous abstinence.

    Time frame: the outcome measure is studied at 6 and 12 months

Secondary outcomes

  1. point prevalence abstinence

    In case ok not reaching abstinence, will be measured if a subject has changed of stage in "transtheoretical model of Prochaska and DiClemente".

    Time frame: the outcome measure is studied at 3, 6 and 12 months

  2. self-reported tobacco consumption

    Time frame: the outcome measure is studied at 3, 6 and 12 months

  3. self-reported smoking reduction

    In case not reaching abstinence

    Time frame: the outcome measure will be studied at 3, 6 and 12 months

  4. stage of change in Prochaska cycle

    Time frame: the outcome measure will be studied at 3,6 and 12 months

  5. used time by professionals to achieve patients stop smoking

    Time frame: the outcome measure will be studied at 3, 6 and 12 months

  6. used time by participants

    Time frame: the outcome measure will be studied at 3, 6 and 12 months

  7. cost to get smoking help in primary care service

    The estimated cost of helping people to leave smoking in regular conditions

    Time frame: the outcome measure will be studied at 3, 6 and 12 months

07

Study locations

1 site
  • Jordi Gol i Gurina Foundation. Research Unit of Barcelona. Lifestyles Research Group.
    Barcelona, 08007, Spain
08

References and documents

Publications

  • Diaz-Gete L, Puigdomenech E, Briones EM, Fabregas-Escurriola M, Fernandez S, Del Val JL, Ballve JL, Casajuana M, Sanchez-Fondevila J, Clemente L, Castano C, Martin-Cantera C; Grupo Estudio TABATIC. Effectiveness of an intensive E-mail based intervention in smoking cessation (TABATIC study): study protocol for a randomized controlled trial. BMC Public Health. 2013 Apr 18;13:364. doi: 10.1186/1471-2458-13-364. PubMed 23597262 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 19, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01494246
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborators
Preventive Services and Health Promotion Research Network, Public Health Service of Cataluña, Carlos III Health Institute
Responsible party
Sponsor
First posted
Dec 16, 2011
Start date
Dec 2012
Primary completion
Sep 2013
Completion
Dec 2014 (estimated)
Last update
Jun 19, 2014

Study contacts

José L Ballvé Moreno, MD
study chair · Institut Català de la Salut
Marc Casajuana, Economist
study chair · IDIAP JORDI GOL
Lourdes Clemente, MD
study chair · Servicio Aragones De Salud
Laura Díaz Gete, MD
principal investigator · Institut Català de la Salut
Elena M Briones Carrió, Statistician
study chair · IDIAP JORDI GOL
Mireia Fàbregas Escurriola, MD
study chair · Institut Català de la Salut
Elisa Puigdomènech Puig, Byologist
study chair · IDIAP JORDI GOL
José L del Val, MD
study chair · Institut Català de la Salut
Soraya Fernández Maestre, nurse
study chair · Institut Català de la Salut
Carlos Martín Cantera, MD, Ph D
study chair · Institut Català de la Salut. Research Unit of Barcelona, IDIAP Jordi Gol. Department of Medicine, University Autonomus of Barcelona
Ricardo Almon, MD, PhD
study chair · Family Medicine Research centre School of Health and medical Sciences. Örebro University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion